OTOGENE AG has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CENIX BIOSCIENCE GMBH, HERLEV HOSPITAL and ROUSSY INST GUSTAVE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | Germany | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Peptides | |
#7 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Antz Christof | 8 |
#2 | Ruppersberg J Peter | 7 |
#3 | Loewenheim Hubert | 6 |
#4 | Zenner Hans Peter | 4 |
#5 | Herlitze Stefan | 2 |
#6 | Lowenheim Hubert | 2 |
#7 | Paysan Jacques | 2 |
#8 | Hahn Hartmut | 2 |
#9 | Ruppersberg Peter | 2 |
Publication | Filing date | Title |
---|---|---|
DE10027777A1 | Introducing substances into cells of sensory organs, useful for treating degenerative disorders of ear and eye, uses penetratin as transporter molecule | |
WO9941407A1 | Method for developing a pharmaceutical active ingredient | |
CA2309117A1 | Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear | |
CA2301633A1 | Method and kit for identifying interactions between proteins or peptides |